Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation

Radiographics

Volumn 29, Issue 4, 2009, Pages 981-1000

  Borhani, Amir A ^a   Hosseinzadeh, Keyanoosh ^a   Almusa, Omar ^a   Furlan, Alessandro ^a   Nalesnik, Michael ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LYMPHOPROLIFERATIVE DISEASE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70349561480     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.294095020     Document Type: Article

References (75)

1. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007; 25:587-617.
2. Snow AL, Martinez OM. Epstein-Barr virus: evasive maneuvers in the development of PTLD. Am J Transplant 2007;7:271-277.
3. Aull MJ, Buell JF, Peddi VR, et al. MALToma: a Helicobacter pylori-associated malignancy in transplant patients-a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation 2003;75:225-228.
4. Shehab TM, Hsi ED, Poterucha JJ, Gunaratnam NT, Fontana RJ. Helicobacter pylori-associated gas- tric MALT lymphoma in liver transplant recipients. Transplantation 2001;71:1172-1175.
5. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 1999;13:664-670.
6. Doria C, Marino IR, Scott VL, et al. Posttransplant lymphoproliferative disorders presenting at sites of previous surgical intervention. Transplantation 2003;75:1066-1069.
7. Birkeland SA. Chronic antigenic stimulation from the graft as a possible oncogenic factor after renal transplant. Scand J Urol Nephrol 1983;17:355-359.
8. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;41:4262-4279.
9. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41:4253-4261.
10. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occur- ring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-192.
11. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplant lymphoproliferative disorders. Blood 1995;85:552-565.
12. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 1997;14:8-14.
13. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC, 2001; 264-269.
14. Tsao L, Hsi ED. The clinicopathologic spectrum of post-transplant lymphoproliferative disorders. Arch Pathol Lab Med 2007;131:1209-1218.
15. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719-727.
16. Hayden RT, Hokanson KM, Pounds SB, et al. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol 2008;46:157-163.
17. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997;35:1612-1615.
18. Manez R, Breinig MC, Linden P, et al. Post- transplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997;176:1462-1467.
19. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004;4:222-230.
20. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001;3:70-78.
21. Shpilberg O, Wilson J, Whiteside TL, Herberman RB. Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case- control study-the University of Pittsburgh PTLD Study Group. Leuk Lymphoma 1999;36:109-121.
22. Newell KA, Alonso EM, Kelly SM, Rubin CM, Thistlethwaite JR Jr, Whitington PF. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of post-transplant lymphoproliferative disease in children. J Pediatr 1997;131:98-104.
23. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttrans- plant lymphoproliferative disorders. Am J Surg Pathol 1990;14(suppl 1):92-100.
24. von Schulthess GK, Hany TF. Imaging and PET- PET/CT imaging. J Radiol 2008;89(3 pt 2):438-448.
25. von Schulthess GK, Steinert HC, Hany TF. Inte- grated PET/CT: current applications and future directions. Radiology 2006;238:405-422.
26. Bakker NA, Pruim J, de Graaf W, van Son WJ, van der Jagt EJ, van Imhoff GW. PTLD visualization by FDG-PET: improved detection of extranodal localizations. Am J Transplant 2006;6:1984-1985.
27. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Presentation and early detection of post- transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int 2007;20:207-218.
28. Bianchi E, Pascual M, Nicod M, Delaloye AB, Duchosal MA. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation 2008; 85:707-712.
29. McCormack L, Hany TI, Hubner M, et al. How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? Am J Transplant 2006;6:1731-1736.
30. O'Conner AR, Franc BL. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation. Nucl Med Commun 2005;26:1107-1111.
31. Nalesnik MA. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis 2001;3:88-96.
32. Aull MJ, Buell JF, Trofe J, et al. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation 2004;78:1676-1682.
33. Knoop C, Kentos A, Remmelink M, et al. Post- transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission. Clin Transplant 2006;20:179-187.
34. Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J. Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol 2007;80:337-346.
35. Pickhardt PJ, Siegel MJ. Post-transplant lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology 1999;213:73-78.
36. Wu L, Rappaport DC, Hanbidge A, Merchant N, Shepherd FA, Greig PD. Lymphoproliferative disorders after liver transplantation: imaging features. Abdom Imaging 2001;26:200-206.
37. Patel H, Vogl DT, Aqui N, et al. Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases. Leuk Lymphoma 2007;48:885-891.
38. Dodd GD 3rd, Greenler DP, Confer SR. Thoracic and abdominal manifestations of lymphoma occurring in the immunocompromised patient. Radiol Clin North Am 1992;30:597-610.
39. Paraskevas S, Coad JE, Gruessner A, et al. Post- transplant lymphoproliferative disorder in pancreas transplantation: a single-center experience. Transplantation 2005;80:613-622.
40. Bates WD, Gray DW, Dada MA, et al. Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol 2003;56:439-446.
41. Caillard S, Lelong C, Pessione F, Moulin B. Post- transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant 2006;6:2735-2742.
42. Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest 2003;124:1242-1249.
43. Harris KM, Schwartz ML, Slasky BS, Nalesnik M, Makowka L. Post-transplant cyclosporine- induced lymphoproliferative disorders: clinical and radiologic manifestations. Radiology 1987;162: 697-700.
44. Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol 2005;60:47-55.
45. Fishman EK, Urban BA, Hruban RH. CT of the stomach: spectrum of disease. RadioGraphics 1996; 16:1035-1054.
46. Beaty SD, Silva AC, Depetris G. Incidental hepatic mass. AJR Am J Roentgenol 2008;190(6 suppl): S2-S64.
47. Pickhardt PJ, Siegel MJ. Abdominal manifestations of post-transplant lymphoproliferative disorder. AJR Am J Roentgenol 1998;171:1007-1013.
48. Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 1997;169:1311-1316.
49. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients: clinical experience and risk factor analysis in a single center. Transplantation 1993;56:88-96.
50. Frick MP, Salomonowitz E, Hanto DW, Gedgaudas- McClees K. CT of abdominal lymphoma after renal transplantation. AJR Am J Roentgenol 1984;142: 97-99.
51. Lopez-Ben R, Smith JK, Kew CE 2nd, Kenney PJ, Julian BA, Robbin ML. Focal post-transplant lymphoproliferative disorder at the renal allograft hilum. AJR Am J Roentgenol 2000;175:1417-1422.
52. Miller WT Jr, Siegel SG, Montone KT. Post-transplant lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging 1997;38:569-585.
53. Soler MJ, Puig JM, Mir M, et al. Posttransplant lymphoproliferative disease: treatment and out- come in renal transplant recipients. Transplant Proc 2003;35:1709-1713.
54. Ali MG, Coakley FV, Hricak H, Bretan PN. Complex post-transplant abnormalities of renal allografts: evaluation with MR imaging. Radiology 1999;211:95-100.
55. Claudon M, Kessler M, Champigneulle J, Lefevre F, Hestin D, Renoult E. Lymphoproliferative disorders after renal transplantation: role of medical imaging. Eur Radiol 1998;8:1686-1693.
56. Cohen JI. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 1991;70:137-160.
57. Fishman EK, Kuhlman JE, Jones RJ. CT of lymphoma: spectrum of disease. RadioGraphics 1991; 11:647-669.
58. Meador TL, Krebs TL, Cheong JJ, Daly B, Keay S, Bartlett S. Imaging features of post-transplant lymphoproliferative disorder in pancreas transplant recipients. AJR Am J Roentgenol 2000;174:121-124.
59. Montone KT, Litzky LA, Wurster A, et al. Analysis of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after lung transplantation. Surgery 1996;119:544-551.
60. Pickhardt PJ, Siegel MJ, Anderson DC, Hayashi R, DeBaun MR. Chest radiography as a predictor of outcome in post-transplant lymphoproliferative disorder in lung allograft recipients. AJR Am J Roentgenol 1998;171:375-382.
61. Patel PR. Post-transplant lymphoproliferative disorders. Clin Oncol (R Coll Radiol) 1999;11:118-122.
62. Loren AW, Tsai DE. Post-transplant lymphoproliferative disorder. Clin Chest Med 2005;26:631-645, vii.
63. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985;157:611-614.
64. Tsai DE, Hardy CL, Tomaszewski JE, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001;71:1076-1088.
65. Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ. Primary central nervous system post- transplant lymphoproliferative disorders. Am J Clin Pathol 2004;121:246-253.
66. Pickhardt PJ, Wippold FJ 2nd. Neuroimaging in post-transplant lymphoproliferative disorder. AJR Am J Roentgenol 1999;172:1117-1121.
67. Snanoudj R, Durrbach A, Leblond V, et al. Primary brain lymphomas after kidney transplantation: pre- sentation and outcome. Transplantation 2003;76: 930-937.
68. Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M. Post-transplant lymphoproliferative disorder in children: clinical, histopathologic, and imaging features. Radiology 2000;217:16-25.
69. Loevner LA, Karpati RL, Kumar P, Yousem DM, Hsu W, Montone KT. Post-transplant lymphoproliferative disorder of the head and neck: imaging features in seven adults. Radiology 2000;216: 363-369.
70. Donnelly LF, Frush DP, Marshall KW, White KS. Lymphoproliferative disorders: CT findings in immunocompromised children. AJR Am J Roentgenol 1998;171:725-731.
71. Herrmann BW, Sweet SC, Hayashi RJ, Canter CE, White FV, Lieu JE. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients. Int J Pediatr Otorhinolaryngol 2006;70:303-310.
72. Douglas RS, Goldstein SM, Katowitz JA, et al. Orbital presentation of post-transplant lymphoproliferative disorder: a small case series. Ophthalmology 2002;109:2351-2355.
73. Gordon AR, Loevner LA, Sonners AI, Bolger WE, Wasik MA. Post-transplant lymphoproliferative disorder of the paranasal sinuses mimicking invasive fungal sinusitis: case report. AJNR Am J Neurora- diol 2002;23:855-857.
74. McFarlane R, Hurst S, Sabath D, George E, Argenyi Z. A rare case of plasmacytoma-like post-transplant lymphoproliferative disorder presenting in the skin of a lung transplant patient. J Cutan Pathol 2008;35: 599-602.
75. Schumann KW, Oriba HA, Bergfeld WF, Hsi ED, Hollandsworth K. Cutaneous presentation of post- transplant lymphoproliferative disorder. J Am Acad Dermatol 2000;42:923-926.